Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing

Sophie Uyoga1, Perpetual Wanjiku1, Jesse C Rop1

  • 1KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Insights

Plasmodium falciparum parasite loads correlate with malaria severity. Plasma P. falciparum histidine-rich protein 2 (PfHRP2) levels may help identify high-risk patients and those critically ill from non-malarial causes.

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Clinical Medicine

Background:

  • Previous studies suggest a link between Plasmodium falciparum parasite load and malaria clinical severity.
  • Understanding this relationship is crucial for diagnosing and managing malaria.

Purpose of the Study:

  • To investigate the relationship between Plasmodium falciparum parasite loads and clinical severity in children.
  • To evaluate the utility of P. falciparum histidine-rich protein 2 (PfHRP2) as a severity marker.

Main Methods:

  • Quantified P. falciparum parasite loads in children with severe malaria (n=1544), uncomplicated malaria (n=200), and asymptomatic parasitemia (n=33).
  • Measured plasma P. falciparum histidine-rich protein 2 (PfHRP2) concentrations across severity groups.
  • Analyzed PfHRP2 levels in severe malaria patients with and without invasive bacterial infections.

Main Results:

  • Peripheral parasitemia was highest in uncomplicated malaria, followed by severe and asymptomatic malaria.
  • Plasma PfHRP2 concentrations increased with malaria severity.
  • PfHRP2 levels were significantly lower in severe malaria patients with invasive bacterial infections compared to those without.

Conclusions:

  • Clinical severity of Plasmodium falciparum malaria is strongly associated with parasite burden.
  • Plasma PfHRP2 concentration is a potential biomarker for identifying children at high clinical risk.
  • PfHRP2 testing may aid in identifying critically ill children where malaria is not the primary cause.
Abstract